Ampio Pharmaceuticals’ management team, including its project managers and various advisors and consultants, has extensive experience in entrepreneurial endeavors relevant to the pharmaceutical industry.
Michael Macaluso, Chief Executive Officer, Founder and DirectorMr. Macaluso is the Chief Executive Officer, founder and Director of Ampio Pharmaceuticals, Inc. and DMI Life Sciences, Inc. Mr. Macaluso has extensive entrepreneur experience over the past 20 years. He was the founder and principal of International Printing and Publishing managing all phases of its domestic and international commercial printing operations from 1989 until 1997, the owner of Page International Communications, a manufacturing business, from 1998 until 2001, and in 2001 formed Isolagen, Inc, serving as a Director and as President and Chief Executive Officer. Mr. Macaluso is a graduate of Canisius College.
David Bar-Or, M.D., Chief Scientific Officer and Director
Dr. Bar-Or is Chief Scientific Officer and Director of Ampio Pharmaceuticals, Inc. and held the same positions for DMI Life Sciences, Inc. He founded DMI BioSciences, Inc. in 1990, serving as Chief Scientific Officer and Director. Dr. Bar-Or has over thirty-five years experience in biochemical/molecular biology research, is a Fellow of the American College of Emergency Physicians, and was in clinical practice for twenty three years, including five years as director of emergency medicine at an accredited trauma center. He is presently Director of Trauma Research for two level one trauma Centers: Swedish Medical Center and St. Anthony Central Hospital. Dr. Bar-Or received his M.D. from Hebrew University Medical School, Jerusalem, Israel, completed his residency in Emergency Medicine at Denver Health Medical Center and was the first to complete a fellowship in Emergency Medicine research at Denver Health Medical Center, a program recognized nationally as a leader in emergency medicine. Dr. Bar-Or has received numerous awards for outstanding clinical and scientific research, published over 85 scientific articles, holds over 52 issued US and international patents, and has filed over 119 additional US and international patent applications.
Vaughan Clift, M.D., Chief Regulatory Affairs Officer
Dr. Clift is the Chief Regulatory Affairs Officer for Ampio Pharmaceuticals, Inc., having also held that position for DMI Life Sciences, Inc. Trained in Endocrinology at the Royal Children's Hospital in Melbourne, Dr. Clift developed numerous medical technologies and was Chief Scientist for Lockheed Martin's, astronautics support program at NASA Johnsons Space Center. During his time at NASA he was co-investigator on multiple space shuttle and space station experiments and was nominated as one of NASA's Top Ten inventors. He was featured in a 30 min ABC science show titled "NASA man" shown on Nova and numerous related science shows. Dr. Clift subsequently went on to successfully develop the first FDA approved autologous cell therapy. He has recently worked with Maj. Gen. Charles F. Bolden, Jr, NASA Administrator, on the development of technology for explosive detection.
Mark McGregor, Chief Financial Officer
Mr. McGregor is a certified public accountant with over 30 years' financial experience in a variety of industries. Mr. McGregor served in various financial capacities with Louisville, Colorado-based Storage Technology Corporation, or StorageTek, from February 1985 until October 2005. During this period, Mr. McGregor held three positions with StorageTek, including director of revenue management (1985-1987), assistant corporate controller (1987-1993), and vice president, corporate treasurer and corporate development (1993-2005). In these positions, Mr. McGregor's responsibilities included treasury and risk management, developing financial strategic plans, cash management and investments, managing foreign currency and interest rate exposures, credit provider and credit rating agency relations, and insurance risk management. His responsibilities also included corporate and international consolidation and reporting, SEC and management reporting, financial integration, disbursements operations, evaluating potential acquisitions, conducting financial due diligence, negotiating credit line provisions to promote operating flexibility, optimizing capital structures, and implementing stock buy-back programs to enhance stockholder value. Mr. McGregor was directly involved in two divestitures and four acquisitions while with StorageTek, in addition to leading the deal team in connection with the sale of StorageTek to Sun Microsystems in 2005. After leaving StorageTek, Mr. McGregor served as the chief financial officer of Integrated Management Information, Inc., Castle Rock, Colorado, from February 2006 to November 2007. IMI is a publicly-traded provider of identification, verification and communications solutions for the agriculture, livestock, and food industries. Since retiring as chief financial officer of IMI in November 2007, Mr. McGregor has been engaged part-time in the real estate business as an agent with Keller Williams Realty in Castle Rock, Colorado. He began his career with Price Waterhouse, now PricewaterhouseCoopers LLP, where he spent 13 years with the Audit Department. Mr. McGregor holds a BBA degree in accounting from Texas A&M University and served in the United States Army from 1964 to 1966, where he attained the rank of First Lieutenant.
Learn More About:
Premature Ejaculation (PE)
Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.
Diabetic Retinopathy
A complication of diabetes mellitus that damages the retina in the eyes and leads to blindness
Diabetic Nephropathy
A progressive complication of diabetes mellitus that leads to end-stage renal disease (ESRD) requiring kidney transplantation or chronic dialysis
| AMPE Stock Quote - delayed | ||
| Last | Change | |
| AMPE | 2.67 |  0.14 (4.98%) |
Ampio News
05/14/2012 | Press Release
Ampio Pharmaceuticals Schedules 2012 Update Webcast
05/11/2012 | Press Release
04/30/2012 | Press Release